U.S. meningitis outbreak claims three more lives

NASHVILLE, Tennessee Tue Oct 9, 2012 7:56pm EDT

1 of 4. A security guard looks out from the front doors of pharmaceutical compounding company New England Compounding Center (NECC), a producer of the steroid methylprednisolone acetate, in Framingham, Massachusetts October 8, 2012.

Credit: Reuters/Jessica Rinaldi

Related Topics

Related Interactive

NASHVILLE, Tennessee (Reuters) - A rare outbreak of fungal meningitis linked to steroid injections has claimed three more lives and New Jersey became the tenth state to report at least one case of the illness in a widening health scare, health authorities said on Tuesday.

The Centers for Disease Control confirmed that two more people had died from meningitis in Tennessee, and one more in Michigan after receiving injections of potentially tainted steroid, bringing the number of deaths nationwide to 11.

The number of people sickened reached 119 on Tuesday, 14 cases more than had been reported by Monday.

The potentially tainted steroid vials, which have been recalled, were shipped to 76 facilities in 23 states and some 13,000 people may have received injections from the medications, the CDC has said.

The New Jersey Department of Health said a 70-year-old Cumberland County, New Jersey man was hospitalized with apparent fungal meningitis, the first case in that state.

"He developed headaches and went to the emergency room with fever and continued headaches," the New Jersey agency said, adding that he was receiving anti-fungal medication at South Jersey Healthcare Regional Medical Center in Vineland.

The widening outbreak has alarmed U.S. health officials and focused attention on regulation of pharmaceutical compounding companies such as the one that produced the drugs, the New England Compounding Center Inc in Framingham, Massachusetts.

The federal Food and Drug Administration regulates only the ingredients and not the compounders, which are subject to a patchwork of state oversight.

Three Democratic members of the U.S. House of Representatives called on Tuesday for a congressional probe of the meningitis outbreak.

"This incident raises serious concerns about the scope of the practice of pharmacy compounding in the United States and the current patchwork of federal and state laws," the Democrats Henry Waxman, Frank Pallone and Diana DeGette said in a letter.

Some of the thousands of people at risk of contracting meningitis may have to wait anxiously for weeks because the incubation period of the disease is up to a month, health experts said.

Tennessee is the hardest hit state with six deaths and 39 cases of meningitis, followed by Michigan with three deaths and 25 cases, Virginia with one death and 24 cases and Maryland with one death and eight cases.

The other states with cases are Indiana (12), Florida (4), Minnesota (3), North Carolina (2), Ohio (1) and New Jersey (1).

Meningitis is an infection of the membranes covering the brain and spinal cord. It is not contagious.

(Writing by Greg McCune; Editing by Claudia Parsons)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (2)
RobinLee wrote:
Was any of this used for veterinary patients? They haven’t said. But vets prescribe medications that compounding pharmacies make.

Oct 09, 2012 12:56pm EDT  --  Report as abuse
neahkahnie wrote:
Of Course, Congress will not ask for more regulations. We all know that industry polices there own so well. Quality control and all that stuff. It’s little better than in the early 1900s when TR called for and got the FDA. Quality control costs too much. Now, I’ll bet that this company gets sued for all. It will declare bankruptcy but the CEO and his buddies will walk away scot free.

Oct 09, 2012 3:39pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

Full focus